24 November 2021: Clinical Research
Discoidin Domain Receptor Tyrosine Kinase 1 (DDR1): A Novel Predictor for Recurrence of Hepatocellular Carcinoma After Curative Resection
Meng Xu CDEFG , Chenghao Cui AB*DOI: 10.12659/MSM.933109
Med Sci Monit 2021; 27:e933109
Figure 3 DDR1 was a promising marker of prognosis for HCC patients in the low-risk HCC group. (A) Kaplan-Meier analysis of TTR evaluated with DDR1 expression in serum and tumors. (B) Kaplan-Meier analyses of TTR according to DDR1 in the low AFP (≤400 ng/ml) group, the single-tumor group, the tumor size ≤5 cm group, and the BCLC 0-A group.